{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:27:45Z","timestamp":1783024065034,"version":"3.54.6"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>\n                    A 14-year-old boy with inguinal lymphadenopathy and scrotal swelling was diagnosed with perineal rhabdomyosarcoma (RMS) via lymph node biopsy. Initial staging with\n                    <jats:sup>18<\/jats:sup>\n                    F-FDG PET\/CT revealed hypermetabolic lymph nodes and a perineal mass overlooked on contrast-enhanced CT assessment. A complementary\n                    <jats:sup>68<\/jats:sup>\n                    Ga-FAPI-46 PET\/CT scan demonstrated comparable lesion detection with higher target-to-background contrast in the primary tumor located in the perineum. This case highlights the diagnostic value of FAP-targeted imaging in pediatric RMS and supports its potential theranostic role in soft tissue sarcomas, expanding current understanding of FAPI avidity in this rare tumor subtype.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000006331","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:00:08Z","timestamp":1771002008000},"page":"e699-e701","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Comparable Diagnostic Performance of 68Ga-FAPI and 18F-FDG PET\/CT in Perineal Rhabdomyosarcoma"],"prefix":"10.1097","volume":"51","author":[{"given":"Sara","family":"Shakeri","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Cancer Research Center, RAZAVI Hospital, Imam Reza International University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Saber Tanha","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid","family":"Jafari Zarrin Ghabaei","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Taheri","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7664-0691","authenticated-orcid":false,"given":"Ramin","family":"Sadeghi","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"R1-20260702","article-title":"99mTc-FAPI-46 scintigraphy and radioligand therapy with 177Lu-FAPI-2286 in locally advanced epithelioid sarcoma","author":"Raeisi","year":"2025","journal-title":"Clin Nucl Med"},{"key":"R2-20260702","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1097\/RLU.0000000000005977","article-title":"99mTc-FAPI-46 scintigraphy in recurrence of low-grade myofibroblastic sarcoma","volume":"51","author":"Raeisi","year":"2025","journal-title":"Clin Nucl Med"},{"key":"R3-20260702","doi-asserted-by":"crossref","first-page":"e494","DOI":"10.1097\/RLU.0000000000005738","article-title":"Metastasis workup for alveolar paratesticular rhabdomyosarcoma","volume":"50","author":"Saber Tanha","year":"2025","journal-title":"Clin Nucl Med"},{"key":"R4-20260702","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1053\/j.semnuclmed.2024.01.001","article-title":"Fibroblast activation protein inhibitor (FAPI) PET imaging in sarcomas: a new frontier in nuclear medicine","volume":"54","author":"Giammarile","year":"2024","journal-title":"Semin Nucl Med"},{"key":"R5-20260702","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2967\/jnumed.121.262096","article-title":"68 Ga-FAPI as a diagnostic tool in sarcoma: data from the 68 Ga-FAPI PET prospective observational trial","volume":"63","author":"Kessler","year":"2022","journal-title":"J Nucl Med"},{"key":"R6-20260702","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1007\/s00259-021-05374-4","article-title":"Novel FAP ligands enable improved imaging contrast in sarcoma patients due to FAPI-PET\/CT","volume":"48","author":"Koerber","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R7-20260702","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1158\/1078-0432.CCR-22-1432","article-title":"Safety and efficacy of 90Y-FAPI-46 radioligand therapy in patients with advanced sarcoma and other cancer entities","volume":"28","author":"Fendler","year":"2022","journal-title":"Clin Cancer Res"},{"key":"R8-20260702","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1007\/s00259-021-05273-8","article-title":"[153Sm]Samarium-labeled FAPI-46 radioligand therapy in a patient with lung metastases of a sarcoma","volume":"48","author":"Kratochwil","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R9-20260702","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s00432-024-05980-3","article-title":"Prognostic factors in clear cell sarcoma: an analysis of soft tissue sarcoma in 43 cases","volume":"150","author":"Grothues","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"key":"R10-20260702","doi-asserted-by":"crossref","first-page":"e209","DOI":"10.1097\/RLU.0000000000005605","article-title":"Application of 99mTc-FAPI-46 imaging in a patient with medullary thyroid carcinoma","volume":"50","author":"Raeisi","year":"2025","journal-title":"Clin Nucl Med"},{"key":"R11-20260702","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1097\/RLU.0000000000005728","article-title":"177Lu-FAPI-2286 therapy in a patient with radio-iodine refractory papillary thyroid carcinoma: a favorable clinical and biochemical response","volume":"50","author":"Raeisi","year":"2025","journal-title":"Clin Nucl Med"},{"key":"R12-20260702","doi-asserted-by":"crossref","first-page":"e564","DOI":"10.1097\/RLU.0000000000005753","article-title":"Favorable palliative effect of 177Lu-FAPI-2286 in two breast cancer patients with refractory bone pains","volume":"50","author":"Raeisi","year":"2025","journal-title":"Clin Nucl Med"},{"key":"R13-20260702","doi-asserted-by":"crossref","first-page":"e651","DOI":"10.1097\/RLU.0000000000004275","article-title":"68Ga-FAPI versus 18F-FDG PET\/CT in recurrent undifferentiated pleomorphic sarcoma of colon mesentery","volume":"47","author":"Zhang","year":"2022","journal-title":"Clin Nucl Med"},{"key":"R14-20260702","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s13139-025-00936-y","article-title":"Exploring the diagnostic and theranostic role of FAPI PET in soft tissue sarcoma: a systematic review","volume":"59","author":"Abdulrahman","year":"2025","journal-title":"Nucl Med Mol Imaging"},{"key":"R15-20260702","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/j.semnuclmed.2025.05.003","article-title":"Fibroblast activation protein inhibitor (FAPI) PET in sarcoma: an update and future perspective","volume":"55","author":"Delgado Bolton","year":"2025","journal-title":"Semin Nucl Med"},{"key":"R16-20260702","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.2967\/jnumed.125.270186","article-title":"Efficacy and safety of [177 Lu]Lu-DOTAGA.Glu.(FAPi) 2 therapy in patients with sarcoma","volume":"66","author":"Ballal","year":"2025","journal-title":"J Nucl Med"},{"key":"R17-20260702","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1097\/RLU.0000000000005255","article-title":"First experience of radionuclide therapy with 177Lu-FAPI-2286 in a patient with metastatic mediastinal sarcoma","volume":"49","author":"Banihashemian","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R18-20260702","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/RLU.0000000000004141","article-title":"68Ga-FAPI-04 versus 18F-FDG PET\/CT in a case with intimal sarcoma of the pulmonary artery","volume":"47","author":"Dong","year":"2022","journal-title":"Clin Nucl Med"},{"key":"R19-20260702","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/RLU.0000000000005274","article-title":"Pleural spindle cell sarcoma on 68Ga-DOTA-FAPI-04 PET\/CT and 18F-FDG PET\/CT","volume":"49","author":"Cui","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R20-20260702","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/RLU.0000000000004986","article-title":"18F-FDG PET\/CT versus 68Ga-FAPI PET\/CT in a case of isolated nodal-type follicular dendritic cell sarcoma","volume":"49","author":"Li","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R21-20260702","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1002\/jor.24387","article-title":"Epidemiology, incidence, and survival of rhabdomyosarcoma subtypes: SEER and ICES database analysis","volume":"37","author":"Amer","year":"2019","journal-title":"J Orthopaed Res"},{"key":"R22-20260702","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/RLU.0000000000003716","article-title":"Increased 68Ga-FAPI uptake in neurofibromatosis in a patient with pleomorphic rhabdomyosarcoma","volume":"46","author":"Wu","year":"2021","journal-title":"Clin Nucl Med"},{"key":"R23-20260702","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/RLU.0000000000005599","article-title":"Adult embryonal rhabdomyosarcoma of the prostate presented on 18F-FDG and Al18F-FAPI-74 PET\/CT","volume":"50","author":"Cheng","year":"2025","journal-title":"Clin Nucl Med"},{"key":"R24-20260702","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.3390\/diagnostics13183006","article-title":"Comparison of 18F-FDG PET\/CT and 68Ga-FAPI in spindle cell rhabdomyosarcoma","volume":"13","author":"Shen","year":"2023","journal-title":"Diagnostics"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006331","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:10:30Z","timestamp":1783023030000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006331","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"2025-10-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}